Prosecution Insights
Last updated: April 19, 2026

Leap Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17779002 METHODS OF TREATING CANCER USING DKK-1 INHIBITORS SULLIVAN, DENNIS JOHN 1642 Non-Final OA May 23, 2022
17761946 USE OF DKK-1 INHIBITORS FOR TREATING CANCER LU, CHENG 1642 Non-Final OA Mar 18, 2022

Managing Leap Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month